Akoya Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Hey, everyone. I'm Tejas Savant, and I cover the Life Science Tools and Diagnostics sector here at Morgan Stanley. Before we begin, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your Morgan Stanley sales rep. So it's my pleasure this morning to host Akoya, and speaking on behalf of the company, we have Brian McKelligon, CEO, and John Ek, CFO. Thank you, both, gents, for doing this.
Questions & Answers
Maybe, Brian, just to set the stage, you recently achieved the 1,000th instrument milestone. Can you take a few minutes to just recap your approach to spatial biology. How does it differ from other players in the market? And why that's a good thing and highlight some of the achievements that you're most proud of (inaudible).
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |